-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Elobixibat is an ileal bile acid transporter (IBAT) inhibitor that increases the concentration of bile acid in the colon and stimulates intestinal function.
A total of 30 patients were enrolled in the study and received 10 mg of elobixibat daily for 2 weeks.
The results showed that the frequency of bowel movements in patients before and after treatment with elobixibat was 7 and 10 times per two weeks, respectively (P <0.
In summary, the results of this study show that short-term treatment of elobixibat increases the concentration of total bile acid and deoxycholic acid, and reduces the diversity of the fecal microbiota.
Original source:
Noboru Misawa, et al.
Leave a message here